The UF Health Myositis Interstitial Lung Disease (ILD) Center provides personalized care and leads research for people with myositis-associated ILD. This includes conditions like inflammatory myopathies, dermatomyositis, and amyopathic dermatomyositis.
Our team
Your multidisciplinary care team includes:
Definition
Myositis Interstitial Lung Disease (ILD) is a disease that causes inflammation in the muscles and lungs. Muscle inflammation can make movement hard, while lung inflammation can cause trouble breathing. It is part of a group of diseases called inflammatory myopathies, which can affect other parts of the body too.
Alternative names
Antisynthetase syndrome; Autoimmune connective tissue disease ILD; Myositis associated ILD; Myositis associated interstitial lung disease; Overlap syndrome
Description
Myositis ILD occurs when diseases like dermatomyositis or antisynthetase syndrome inflame the lungs. This can lead to scarring and lung damage, including pulmonary fibrosis and interstitial pneumonia.
Other conditions, like infectious diseases or gastroesophageal junction (GEJ) cancers, have similar symptoms. A thorough diagnosis helps differentiate idiopathic inflammatory myopathies from these conditions.
Symptoms
Myositis ILD symptoms vary, but commonly include:
Talk to a doctor if you notice these symptoms, especially if you already have a muscle disease like myositis.
Diagnosis
To diagnose myositis-associated ILD, your doctor will do a physical exam and ask about your health history. Tests that may be used include:
A thorough diagnosis helps differentiate idiopathic inflammatory myopathies from other conditions like infectious diseases or gastroesophageal junction (GEJ) cancers, which may mimic similar symptoms.
Treatment
There is no cure yet, but treatment can reduce symptoms and slow down lung damage. Treatment plans are made for each person and may include:
- Corticosteroids (e.g., prednisone) to manage inflammation
- Immunosuppressive drugs such as mycophenolate mofetil (a steroid alternative)
- Intravenous Immunoglobulin (IVIG) for severe cases
- Oxygen therapy and pulmonary rehabilitation
- Physical therapy to maintain muscle strength
- Steroids
In severe cases, lung transplants may be considered. Doctors will monitor for side effects like infections or high blood pressure, especially from steroids or immune-suppressing medicines.
Complications
Complications of myositis ILD include:
Discussing potential side effects of treatments with your doctor and reporting any new or worsening symptoms is crucial.
Living with Myositis ILD
Managing life with myositis-associated ILD requires lifestyle adjustments and careful adherence to treatment plans. Here are some tips:
- Follow prescribed treatments to control inflammation and prevent further lung damage.
- Stay active with lighter exercises or physical therapy to maintain muscle strength.
- Monitor your symptoms for changes in breathing, fatigue, or muscle strength.
- Manage stress and seek emotional support from therapists or support groups. The Myositis Association or the Pulmonary Fibrosis Foundation both provide this support.
Research and clinical trials
Research
Our research focuses on advancing the understanding of Myositis ILD to develop effective and evidence-based treatments for our patients.
We encourage you to ask about our research, explore ways to participate and support our cause.
Clinical trials
For more information, call (352) 273-8737.
Join our community
Attend our monthly ILD Support Group meeting, hosted by UF Health’s ILD physicians and clinical research coordinators. Each session features a presentation by an expert on a relevant ILD topic. Patients have a chance to learn more about their condition, connect with others, and share experiences.
Meetings are held on Thursdays at 4 p.m. on the UF campus. There is also a Zoom option for remote participation.
Reach out to caroline.cook@medicine.ufl.edu or rosie.kizza@medicine.ufl.edu if you would like to learn more.
Related specialties
This entry was written by Jennifer Cruz-Urbano, Marketing Specialist, and reviewed for accuracy by Faye M. Pais, Assistant Professor of Medicine. Generative AI was leveraged as part of the content creation process.